Here is the part most guides skip: Ozempic and Wegovy are the same molecule. Same semaglutide, same mechanism, same class. The real difference is dose — Wegovy is built for weight loss and runs at a higher dose (2.4 mg vs up to 2.0 mg), which is exactly why it produces bigger weight loss and, honestly, more nausea.
| A | B | |
|---|---|---|
| Purpose | Type 2 diabetes | Weight loss |
| Active ingredient | Semaglutide | Semaglutide (identical) |
| Peak dose | 2.0 mg weekly | 2.4 mg weekly |
| Average weight loss | ~6-7% (diabetes trials) | 14.9% (STEP 1) |
| Nausea reported | ~20-44% | ~44% in STEP 1 |
The same judgment framework runs across this site — protein, fiber and how heavy a food sits on a slow stomach.
| Easy on both | Risky on both |
|---|---|
|
|
Yes — the judgment framework is identical because the drug is identical. The difference is that at Wegovy's higher dose, foods that sit on the edge (rich, fatty, large portions) are more likely to trigger nausea, so leaner choices matter more.
Wegovy. STEP 1 reported nausea in about 44% of people on the 2.4 mg dose, and side effects generally track the dose. That is also why dose increases are slow and food choices become a bigger factor as the dose climbs.
Yes — constipation comes from the drug class, not the brand. Either way, the fix is the same: fiber toward 25 g a day plus water, increased gradually.
This comparison presents published trial data (STEP, SURMOUNT, SCALE, OASIS 4) and FDA label information for reference. It is not medical advice and does not recommend any medication. Prescription decisions belong to you and your healthcare provider.